首页|miR-193b-3p过表达的HCT116外泌体对HUVEC增殖凋亡、迁移、血管形成影响及其与PAK4靶向关系

miR-193b-3p过表达的HCT116外泌体对HUVEC增殖凋亡、迁移、血管形成影响及其与PAK4靶向关系

扫码查看
目的 观察微小核糖核酸193b-3p(miR-193b-3p)过表达的人结直肠癌(CRC)细胞(HCT116)外泌体对人脐静脉内皮细胞(HUVEC)增殖凋亡、迁移、血管形成影响,并分析miR-193b-3p与p21活化蛋白激酶4(PAK4)的靶向关系。方法 收集CRC患者血清和HCT116细胞上清外泌体,透射电镜实验和纳米颗粒示踪分析观察和鉴定外泌体,RT-qPCR实验检测外泌体miR-193b-3p和PAK4 mRNA。取人脐静脉内皮细胞(HUVEC),并分组,PBS组加入100 µL的PBS,HCT116-Exo组加入100 µL的HCT116细胞外泌体,HCT116-Exo+GW4869组先用GW4869(10 µmol/L)处理30 min,然后加入100 µL的HCT116细胞外泌体,采用EdU实验、Transwell实验和成管实验检测各组HUVEC细胞增殖、迁移和血管形成能力。取对数生长期的HUVEC细胞,并分为miR-NC组、miR-193b-3p组,miR-NC组与转染miRNA阴性对照(miR-NC)的HCT116细胞外泌体共培养,miR-193b-3p组与转染miR-193b-3p模拟物(miR-193b-3p mimics)的HCT116细胞外泌体共培养,采用CCK8实验、流式细胞术实验和成管实验检测各组HUVEC细胞活性、细胞周期、细胞凋亡和血管形成能力。双荧光素酶报告基因系统检测miR-193b-3p和PAK4的靶向关系。结果 CRC患者血清和细胞外泌体miR-193b-3p表达升高,PAK4 mRNA表达降低(P均<0。05);CRC细胞外泌体可促进HUVEC细胞的增殖、迁移和血管形成(P均<0。05);过表达CRC细胞外泌体miR-193b-3p增加HUVEC细胞活力和血管形成、加速细胞周期进程、抑制细胞凋亡(P均<0。05);miR-193b-3p直接靶向PAK4抑制其荧光素酶活性(P<0。05)。结论 CRC血清、癌细胞外泌体miR-193b-3p表达升高,加入HCT116细胞外泌体的HUVEC细胞增殖、迁移和血管形成能力增强,加入转染miR-193b-3p mimics HCT116细胞外泌体的HUVEC细胞增殖、S期占比、血管形成能力升高及G0/G1期占比、凋亡率下降,miR-193b-3p与PAK4存在靶向关系。
Effects of exosomes from HCT116 cells overexpressing miR-193b-3p on proliferation,apoptosis,migration and angiogenesis of HUVEC and their targeted relationship with PAK4
Objective To observe the effects of exosomes from human colorectal cancer(CRC)cells(HCT116)with overexpression of microRNA 193b-3p(miR-193b-3p)on the proliferation,apoptosis,migration and angiogenesis of human umbilical vein endothelial cells(HUVECs),and to analyze the targeted relationship between miR-193b-3p and p21-activated kinase 4(PAK4).Methods Serum from CRC patients and exosomes in the supernatant of HCT116 cells were collected.Transmission electron microscopy and nanoparticle tracking analysis were used to observe and identify exo-somes.RT-qPCR was performed to detect exosomal miR-193b-3p and PAK4 mRNA.HUVECs were taken and grouped.HUVECs in the PBS group were added with 100 µL of PBS,HUVECs in the HCT116-Exo group were added with 100 µL of HCT116 cell exosomes,and HUVECs in the HCT116-Exo+GW4869 group were first treated with GW4869(10 µmol/L)for 30 min and then were added with 100 µL of HCT116 cell exosomes.The proliferation,migration and angiogenesis abili-ties of HUVECs in each group were detected by EdU assay,Transwell assay and tube formation assay.HUVECs in the log-arithmic growth phase were taken and divided into the miR-NC group and the miR-193b-3p group.HUVECs in the miR-NC group were co-cultured with HCT116 cell exosomes transfected with miRNA negative control(miR-NC),and the miR-193b-3p group with HCT116 cell exosomes transfected with miR-193b-3p mimics.The activity,cell cycle,apoptosis and angiogenesis ability of HUVECs in each group were detected by CCK-8 assay,flow cytometry and tube formation as-say.The targeted relationship between miR-193b-3p and PAK4 was detected by the dual-luciferase reporter gene sys-tem.Results The expression of miR-193b-3p in serum and exosomes of CRC patients increased,while the expression of PAK4 mRNA decreased(both P<0.05);exosomes could promote the proliferation,migration,and angiogenesis of HU-VECs(all P<0.05).Overexpression of miR-193b-3p increased the cell viability and angiogenesis,accelerated cell cycle progression,and inhibited the apoptosis of HUVECs(all P<0.05);miR-193b-3p inhibited its luciferase activity by direct-ly targeting PAK4(P<0.05).Conclusions The expression of miR-193b-3p in exosomes of CRC serum and cancer cells increases,and the proliferation,migration and angiogenesis of HUVECs with the addition of HCT116 exosomes are en-hanced.HUVECs added with HCT116 exosomes transfected with miR-193b-3p mimics show increased proliferation,S phase proportion,angiogenesis ability,and decreased G0/G1 phase proportion and apoptosis rate;miR-193b-3p has a tar-geted relationship with PAK4.

colorectal carcinomaexosomemicroRNA 193b-3pP21-activated kinase 4cell proliferationcell migrationapoptosiscell cycleangiogenesis

孙玮螺、刘素英、李思锦、周龙妹、何培元

展开 >

承德医学院附属医院消化内科,河北承德 067000

结直肠癌 外泌体 微小核糖核酸193b-3p P21活化蛋白激酶4 细胞增殖 细胞迁移 细胞凋亡 细胞周期 血管生成

2023年度河北省医学科学研究课题计划项目

20231365

2024

山东医药
山东卫生报刊社

山东医药

CSTPCD
影响因子:1.225
ISSN:1002-266X
年,卷(期):2024.64(24)